WO2005062991A3 - Ten and 20-di-esterification derivatives of camptothecins and methods to treat cancers - Google Patents
Ten and 20-di-esterification derivatives of camptothecins and methods to treat cancers Download PDFInfo
- Publication number
- WO2005062991A3 WO2005062991A3 PCT/US2004/043978 US2004043978W WO2005062991A3 WO 2005062991 A3 WO2005062991 A3 WO 2005062991A3 US 2004043978 W US2004043978 W US 2004043978W WO 2005062991 A3 WO2005062991 A3 WO 2005062991A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- camptothecins
- methods
- treat cancers
- esterification derivatives
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53194103P | 2003-12-23 | 2003-12-23 | |
US60/531,941 | 2003-12-23 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005062991A2 WO2005062991A2 (en) | 2005-07-14 |
WO2005062991A3 true WO2005062991A3 (en) | 2005-09-29 |
Family
ID=34738721
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/043978 WO2005062991A2 (en) | 2003-12-23 | 2004-12-23 | Ten and 20-di-esterification derivatives of camptothecins and methods to treat cancers |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2005062991A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2009001505A (en) | 2006-08-11 | 2009-03-25 | Christus Stehlin Foundation Fo | Methods of making esters of camptothecins. |
CN101402640B (en) * | 2008-09-02 | 2011-06-15 | 暨南大学 | Diester camptothecin derivative, preparation method and uses thereof |
CN102895229A (en) * | 2012-10-10 | 2013-01-30 | 中国药科大学 | Medical application of camptothecin and its derivative in resisting Alzheimer disease |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6407239B1 (en) * | 1999-08-03 | 2002-06-18 | The Stehlin Foundation For Cancer Research | Aromatic esters of camptothecins and methods to treat cancers |
-
2004
- 2004-12-23 WO PCT/US2004/043978 patent/WO2005062991A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6407239B1 (en) * | 1999-08-03 | 2002-06-18 | The Stehlin Foundation For Cancer Research | Aromatic esters of camptothecins and methods to treat cancers |
Also Published As
Publication number | Publication date |
---|---|
WO2005062991A2 (en) | 2005-07-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004108715A8 (en) | 3-aryloxy and 3-heteroaryloxy substituted benzo(b) thiophenes as therapeutic agents with pi3k activity | |
MXPA04005456A (en) | Acetylene derivatives having mglur 5 antagonistic activity. | |
HK1088845A1 (en) | Use of parthenolide derivatives as antileukemic and cytotoxic agents | |
ATE463478T1 (en) | DIARYL ETHER DERIVATIVE, ITS ADDITION SALT AND IMMUNOSUPPRESSANT | |
AU2003226572A1 (en) | Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors | |
WO2006050161A3 (en) | Therapeutic furopyrimidines and thienopyrimidines | |
WO2004092135A3 (en) | Substituted benzosulphonamide as potentiators of glutamate receptors | |
DK1725536T3 (en) | Imidazoline derivatives with CB1 antagonistic activity | |
WO2006024486A3 (en) | Amide derivatives of 3-phenyl dihydropyrimido[4,5-d]pyrimidinones, their manufacture and use as pharmaceutical agents | |
BRPI0409611A (en) | piperazine derivatives and their use for the treatment of neurological and psychiatric disorders | |
WO2003000699A8 (en) | Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives as medicaments for the treatment of pain | |
MX2007000240A (en) | Phenyl substituted [1.2]-oxazine-3,5-dione and dihydropyrone derivatives. | |
WO2004080922A3 (en) | Substituted vitamin d analogues and their therapeutic uses | |
MY128241A (en) | Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors | |
WO2004110990A3 (en) | Imidazothiazoles and imidazoxazole derivatives as inhibitors of p38 | |
MY133112A (en) | 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use | |
WO2002024697A1 (en) | Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient | |
WO2006110173A3 (en) | Novel compounds | |
MY136297A (en) | Piperazine derivatives having sst1 antagonistic activity | |
WO2004019879A3 (en) | Motilide compounds | |
WO2003015780A3 (en) | Isoxazolopyridinones and use thereof in the treatment of parkinson's disease | |
WO2005062985A3 (en) | Di-ester prodrugs of camptothecin, process for their preparation and their therapeutical applications | |
WO2005062991A3 (en) | Ten and 20-di-esterification derivatives of camptothecins and methods to treat cancers | |
EP1661898A4 (en) | Bicyclic piperazine compound and use thereof | |
WO2004048381A3 (en) | Pyrazoloazepine compounds as pharmaceutical agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
CFP | Corrected version of a pamphlet front page | ||
CR1 | Correction of entry in section i |
Free format text: IN PCT GAZETTE 28/2005 UNDER (81) ADD "SM" |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
122 | Ep: pct application non-entry in european phase |